Welcome to our dedicated page for Saratoga Invt SEC filings (Ticker: SAR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking Saratoga Investment Corp’s shifting loan portfolio, SBIC leverage and CLO exposure can feel like navigating a maze of footnotes. If you have ever typed “Saratoga Investment Corp SEC filings explained simply” into a search bar, you already know how dense a 300-page 10-K can be—and how critical it is to spot covenant breaches or portfolio markdowns before they dent the dividend.
Stock Titan solves that problem. Our AI-powered summaries unpack every 10-K annual report, 10-Q quarterly earnings report and 8-K material event the moment SAR releases them to EDGAR. Need the “Saratoga Investment Corp quarterly earnings report 10-Q filing” without reading tables for hours? We highlight net investment income and non-accrual trends in plain English. Curious about management incentives? The latest “Saratoga Investment Corp proxy statement executive compensation” is distilled so you can compare pay to portfolio returns in minutes. Real-time alerts flag every “Saratoga Investment Corp Form 4 insider transactions real-time,” letting you see “Saratoga Investment Corp executive stock transactions Form 4” before markets react.
Whether you are screening credit quality or watching for buybacks, our coverage delivers what professionals actually need:
- Instant AI summaries that translate complex accounting into clear takeaways
- Live feed of “Saratoga Investment Corp insider trading Form 4 transactions”
- Side-by-side charts for “Saratoga Investment Corp earnings report filing analysis”
- One-click access to “Saratoga Investment Corp annual report 10-K simplified” and every “Saratoga Investment Corp 8-K material events explained”
- Downloadable data tables to power your own models for understanding Saratoga Investment Corp SEC documents with AI
No more combing through PDFs. Stock Titan’s real-time engine surfaces the disclosures that move SAR’s stock—so you can focus on decisions, not document digging.
Silexion Therapeutics Corp (SLXN) has filed an amended Form 8-K to clarify timing details surrounding its Nasdaq listing status.
The Nasdaq hearings panel has granted the company continued listing but will transfer the ordinary shares and warrants from the Nasdaq Global Market to the Nasdaq Capital Market as soon as practicable. While the original filing stated the move could occur on 8 July 2025, the amendment notes the exact date remains uncertain.
Silexion also warns it may become non-compliant with Nasdaq Listing Rule 5550(a)(2) (minimum $1.00 bid price) if its shares close below that threshold for 30 straight trading days. Management intends to cure any deficiency through a 1-for-15 reverse share split, subject to shareholder approval at the reconvened AGM on 14 July 2025. After approval, a mandatory 10-day Nasdaq notice period would push the split to roughly 25 July 2025, with compliance only achieved after the stock trades above $1.00 for 10 consecutive days—placing the earliest compliance window in early-to-mid August 2025.
The company cautions that there is no assurance shareholders will approve the split or that the post-split price will meet Nasdaq requirements, leaving a continued risk of delisting.
On July 2, 2025, Educational Development Corporation (NASDAQ: EDUC) convened its annual meeting of stockholders. Shareholders elected Dr. Amy N. Emerson as a Class III director for a three-year term, receiving 5,074,815 votes for, 0 against, 89,861 withheld, and 1,360,847 broker non-votes. In a second proposal, investors ratified HoganTaylor LLP as the Company’s independent registered public accounting firm for the fiscal year ending February 28, 2026, with 6,257,164 votes for, 18,822 against, 249,537 abstain/withheld, and 0 broker non-votes. No additional matters were submitted for shareholder action.
Atlantic Union Bankshares Corp. (AUB) filed a Form 4 reporting that director Ronald L. Tillett acquired 639 phantom stock units on 01 July 2025 through the company’s non-qualified deferred-compensation plan. Each unit represents the economic value of one share of AUB common stock and will be settled in cash or shares at a future date chosen by the director. The acquisition price reference of $31.28 reflects AUB’s closing price on the trading day prior to the transaction. Following the award, Tillett beneficially owns 9,057.594 phantom stock units, a figure that already includes 92.512 units gained via dividend reinvestment since his last filing. No open-market purchases or sales of AUB common stock were disclosed, and there were no changes to his direct share ownership.
The reported transaction is routine compensation-related activity and does not materially alter the company’s capital structure or indicate a directional view on AUB’s share price. Investors typically view phantom stock accruals as a neutral incentive-alignment mechanism rather than a market signal.
FAQ
What is the current stock price of Saratoga Invt (SAR)?
What is the market cap of Saratoga Invt (SAR)?
What is Saratoga Investment Corp?
What types of financing solutions does the company offer?
How does Saratoga Investment Corp generate returns?
What is the significance of a permanent capital base for Saratoga?
How does the company differentiate itself in the middle market segment?
What is the role of the SBIC-licensed subsidiary and CLO fund?
Why is expertise important in Saratoga's investment strategy?
How does Saratoga support business transitions for its clients?
